Stephen Johnson

Array ( [id] => 9311905 [patent_doc_number] => 08653123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases' [patent_app_type] => utility [patent_app_number] => 13/233382 [patent_app_country] => US [patent_app_date] => 2011-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9855 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13233382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712091 [patent_doc_number] => 20120004274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'USE OF INHIBITORS OF JUN N-TERMINAL KINASES TO TREAT GLAUCOMA' [patent_app_type] => utility [patent_app_number] => 13/232410 [patent_app_country] => US [patent_app_date] => 2011-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4850 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13232410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712063 [patent_doc_number] => 20120004265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Ophthalmic Compositions and Methods of Using the Same' [patent_app_type] => utility [patent_app_number] => 13/229817 [patent_app_country] => US [patent_app_date] => 2011-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6460 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13229817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710151 [patent_doc_number] => 20120003198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Lutein/Zeaxanthin for glare protection' [patent_app_type] => utility [patent_app_number] => 13/137729 [patent_app_country] => US [patent_app_date] => 2011-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1747 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13137729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663764 [patent_doc_number] => 20110313033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'OPHTHALMIC USES OF S1P RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/218707 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5836 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313033.pdf [firstpage_image] =>[orig_patent_app_number] => 13218707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382283 [patent_doc_number] => 20120225918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'Compositions and Methods for Non-Surgical Treatment of Ptosis' [patent_app_type] => utility [patent_app_number] => 13/218584 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12603 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13218584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10114582 [patent_doc_number] => 09149446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Stabilized mutant opsin proteins' [patent_app_type] => utility [patent_app_number] => 13/217128 [patent_app_country] => US [patent_app_date] => 2011-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 10885 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13217128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651981 [patent_doc_number] => 20110301250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Composition for Treating Dry Eye and Related Methods of Manufacture and Methods of Use' [patent_app_type] => utility [patent_app_number] => 13/214306 [patent_app_country] => US [patent_app_date] => 2011-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3857 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301250.pdf [firstpage_image] =>[orig_patent_app_number] => 13214306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784776 [patent_doc_number] => 20120046332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CORNEAL HAZE' [patent_app_type] => utility [patent_app_number] => 13/211715 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5274 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046332.pdf [firstpage_image] =>[orig_patent_app_number] => 13211715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651895 [patent_doc_number] => 20110301164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'METHOD OF ADMINISTERING OPHTHALMIC FLUIDS' [patent_app_type] => utility [patent_app_number] => 13/208477 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1555 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301164.pdf [firstpage_image] =>[orig_patent_app_number] => 13208477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8618208 [patent_doc_number] => 20130023520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'ANAESTHETIC EYE SOLUTION AND METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 13/189526 [patent_app_country] => US [patent_app_date] => 2011-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3085 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13189526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8618263 [patent_doc_number] => 20130023575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR SURFACE ALLERGIES' [patent_app_type] => utility [patent_app_number] => 13/188730 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5973 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13188730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561761 [patent_doc_number] => 20110275594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'Oral dosage form' [patent_app_type] => utility [patent_app_number] => 13/137048 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11101 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275594.pdf [firstpage_image] =>[orig_patent_app_number] => 13137048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733745 [patent_doc_number] => 20120016027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'Composition and Method for Improved Lens Comfort' [patent_app_type] => utility [patent_app_number] => 13/184053 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6612 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20120016027.pdf [firstpage_image] =>[orig_patent_app_number] => 13184053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733566 [patent_doc_number] => 20120015953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALLERGY' [patent_app_type] => utility [patent_app_number] => 13/183194 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3872 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015953.pdf [firstpage_image] =>[orig_patent_app_number] => 13183194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7560916 [patent_doc_number] => 20110274748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'CAI-Based Systems and Methods for the Localized Treatment of Ocular and Other Diseases' [patent_app_type] => utility [patent_app_number] => 13/181847 [patent_app_country] => US [patent_app_date] => 2011-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20182 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20110274748.pdf [firstpage_image] =>[orig_patent_app_number] => 13181847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501843 [patent_doc_number] => 20110263638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Therapeutic agent for glaucoma comprising rho kinase inhibitor and ß- blocker' [patent_app_type] => utility [patent_app_number] => 13/135295 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2848 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263638.pdf [firstpage_image] =>[orig_patent_app_number] => 13135295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670218 [patent_doc_number] => 20110319487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'POLYMERIC DELIVERY SYSTEM FOR A NONVISCOUS PROSTAGLANDIN-BASED SOLUTION WITHOUT PRESERVATIVES' [patent_app_type] => utility [patent_app_number] => 13/170716 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5418 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13170716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511415 [patent_doc_number] => 20110257125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Mucomimetic compositions and uses therefore' [patent_app_type] => utility [patent_app_number] => 13/067762 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3597 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257125.pdf [firstpage_image] =>[orig_patent_app_number] => 13067762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712008 [patent_doc_number] => 20120004245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'COMPOUNDS FOR THE TREATMENT OF POSTERIOR SEGMENT DISORDERS AND DISEASES' [patent_app_type] => utility [patent_app_number] => 13/168271 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6409 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168271 [rel_patent_id] =>[rel_patent_doc_number] =>)